First-line zanidatamab plus chemotherapy leads to ‘practice-changing’ PFS and overall survival gains in a phase 3 study of ...

Perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) demonstrates superior outcomes than preoperative chemoradiotherapy in resectable esophageal adenocarcinoma, ...

The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...

Ever-smokers receiving immunotherapy for gastric and esophageal cancers showed better survival outcomes but higher relapse ...

At a median follow-up of 55 months in the intent-to-treat population of the ESOPEC trial, the FLOT (5-fluorouracil, leucovorin, oxaliplatin, and docetaxel) perioperative protocol significantly ...

Proprietary discovery platform, stemECHO, clones and characterizes the role of epithelial stem cells in the pathogenesis of inflammation and cancer, identifying druggable targets for the treatment and ...

Esophageal cancer represents one of the most challenging and often overlooked digestive system malignancies, developing in the tube that connects your throat to your stomach. This aggressive disease ...

In June, Newport Beach, Calif.-based Hoag b e came the first hospital in the U.S. to offer EsoGuard testing. The test is used by physicians to detect precancerous DNA changes in esophageal cells, ...

(BOSTON) — Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for which no effective targeted therapy exists. Patients need to rely ...

A genetic fault long believed to drive the development of esophageal cancer may in fact play a protective role early in the disease, according to new research published in Nature Cancer. This ...